Zydus Infringed AstraZeneca's Diabetes Drug IP, Judge Rules
By Craig Clough · October 15, 2021, 9:17 PM EDT
A Delaware federal judge held Friday that Zydus Pharmaceuticals infringed an AstraZeneca patent for a diabetes drug, saying Zydus failed during a four-day bench trial to prove that any of the...
To view the full article, register now.